hrs-9563
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 24, 2024 (NCT07117474)
Timeline
Mechanism of action
- AngiotensinogenINHIBITOR
AGT inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07297797 | Phase 2 | Dec 31, 2025 | Jiangsu ShengDiYa Medicine Co., Ltd. |
| NCT07117474 | Phase 1 | Dec 24, 2024 | Jiangsu ShengDiYa Medicine Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu ShengDiYa Medicine Co., Ltd. | Government | 2 | 2 | 2 | 2024 |
1 organizations
Page 1 / 1